• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC. NAVISTAR RMT THERMOCOOL ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC. NAVISTAR RMT THERMOCOOL ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number NR7TCSIY
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Cardiac Tamponade (2226)
Event Date 11/30/2020
Event Type  Injury  
Manufacturer Narrative
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a patient underwent cardiac ablation procedure for atrial fibrillation (afib) with navistar® rmt thermocool® electrophysiology catheter and suffered cardiac tamponade requiring surgical intervention.It was reported that a single transseptal sheath was paced across.The physician mapped the left atrium but could not maneuver the catheter to the left superior pulmonary vein.The physician replaced it with a rmt catheter and could not go posterior in the chamber.It was then noticed that the patient¿s blood pressure dropped to 70mmhg.Through the accunav and transthoracic echo a pericardial effusion was noted.The acunav was in the right atrium.No ablations had been performed.A pericardiocentesis was performed and the patient was transferred to surgery.The surgeon found a hole in the roof of the left atrium.It is believed that this occurred during the transseptal part of the procedure.The patient is stable and recovering.The event is conservatively reported under the ablation catheter.
 
Manufacturer Narrative
On (b)(6) 2021, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Manufacturer Narrative
It was reported that a patient underwent cardiac ablation procedure for atrial fibrillation (afib) with navistar® rmt thermocool® electrophysiology catheter and suffered cardiac tamponade requiring surgical intervention.It was reported that a single transseptal sheath was paced across.Device evaluation details: the device evaluation has been completed.The device was visually inspected and it was found in good conditions.The temperature and electrical features were tested and no issues were observed.In addition, the catheter was irrigating correctly.Then, magnetic sensor functionality was tested on carto and the catheter failed the test since the icon was observed in a reverse position.A failure analysis was performed, the catheter was dissected, and the sensor values were found within product specification, with this information, the failure related with reverse icon can be attributed to a potential pc board failure.A manufacturing record evaluation was performed and no internal actions related to the reported complaint were identified.The customer complaint cannot be confirmed.The root cause of the adverse event remains unknown.The instructions for use (ifu) states that careful catheter manipulation must be performed to avoid cardiac damage, perforation or tamponade.The root cause of the reverse icon or pc board failure identified during product evaluation cannot be determined; potential cause traced to the component failure (circuit board/pc board).Additionally, during product evaluation/testing, the lot number was identified by electronically erasable programmable read only memory (eeprom) as 30410835m.As such, field d4.Lot number has been populated.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR RMT THERMOCOOL ELECTROPHYSIOLOGY CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER INC.
33 technology drive
irvine CA 92618
MDR Report Key11074749
MDR Text Key223799661
Report Number2029046-2020-01984
Device Sequence Number1
Product Code OAD
UDI-Device Identifier10846835008500
UDI-Public10846835008500
Combination Product (y/n)N
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 11/30/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/29/2023
Device Model NumberNR7TCSIY
Device Catalogue NumberNR7TCSIY
Device Lot Number30410835M
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/16/2021
Date Manufacturer Received01/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ACUNAV 8F-90; PENTARAY NAV ECO 7FR, F, 2-6-2; SMARTABLATE GENERATOR KIT-US; SMARTABLATE PUMP KIT-US; ACUNAV 8F-90; PENTARAY NAV ECO 7FR, F, 2-6-2; SMARTABLATE GENERATOR KIT-US; SMARTABLATE PUMP KIT-US
Patient Outcome(s) Life Threatening; Required Intervention;
-
-